Concurrent Reduced Expression of Contiguous PKD1, TSC2 and NTHL1 Leading to Kidney Diseases and Multiple Diverse Renal Cancers
Cancer Genomics - Proteomics · 2023
DOI: 10.21873/cgp.20363 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Genomics - Proteomics, 2023. Verfasst von Satoru Meguro und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Fukushima Medical University School of Medicine, Fukushima, Japan s-meguro@fmu.ac.jp. Hauptthemen laut MEDLINE: Carcinoma, Renal Cell, Deoxyribonuclease (Pyrimidine Dimer), Kidney Neoplasms, Polycystic Kidney, Autosomal Dominant. Die Arbeit wurde bisher 3-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Urology, Fukushima Medical University School of Medicine, Fukushima, Japan s-meguro@fmu.ac.jp.
- Department of Urology, Fukushima Medical University School of Medicine, Fukushima, Japan.
Zitieren
APA
Meguro, S., Koguchi, T., Hakozaki, Y., Onagi, A., Matsuoka, K., Hoshi, S., Hata, J., Sato, Y., Akaihata, H., Kataoka, M., Ogawa, S., & Kojima, Y. (2023). Concurrent Reduced Expression of Contiguous PKD1, TSC2 and NTHL1 Leading to Kidney Diseases and Multiple Diverse Renal Cancers. Cancer Genomics - Proteomics. https://doi.org/10.21873/cgp.20363
Vancouver
Meguro S, Koguchi T, Hakozaki Y, Onagi A, Matsuoka K, Hoshi S, et al. Concurrent Reduced Expression of Contiguous PKD1, TSC2 and NTHL1 Leading to Kidney Diseases and Multiple Diverse Renal Cancers. Cancer Genomics - Proteomics. 2023. doi:10.21873/cgp.20363
BibTeX
@article{Meguro2023,
author = {Meguro, Satoru and Koguchi, Tomoyuki and Hakozaki, Yusuke and Onagi, Akifumi and Matsuoka, Kanako and Hoshi, Seiji and Hata, Junya and Sato, Yuichi and Akaihata, Hidenori and Kataoka, Masao and Ogawa, Soichiro and Kojima, Yoshiyuki},
title = {Concurrent Reduced Expression of Contiguous PKD1, TSC2 and NTHL1 Leading to Kidney Diseases and Multiple Diverse Renal Cancers},
journal = {Cancer Genomics - Proteomics},
year = {2023},
doi = {10.21873/cgp.20363}
}
EUVIMED